Lanraplenib monosuccinate is a highly selective inhibitor of spleen tyrosine kinase (SYK), with an IC50 of 9.5 nM. This compound inhibits SYK activity in platelets through the glycoprotein VI (GPVI) receptor, making it a promising candidate for the treatment of inflammatory diseases. Notably, lanraplenib monosuccinate does not prolong bleeding time in preclinical models, indicating a favorable safety profile for potential therapeutic applications.
Lanraplenib monosuccinate is a highly selective inhibitor of spleen tyrosine kinase (SYK), with an IC50 of 9.5 nM. This compound inhibits SYK activity in platelets through the glycoprotein VI (GPVI) receptor, making it a promising candidate for the treatment of inflammatory diseases. Notably, lanraplenib monosuccinate does not prolong bleeding time in preclinical models, indicating a favorable safety profile for potential therapeutic applications.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
